AHA Scientific Sessions 2025 Abstract
Tirzepatide Reduces the Risk of Major Adverse Cardiovascular Events: An Individual Participant Data Meta-analysis of Phase 3 Randomized Clinical Trials
Meta-analysis of randomized trialsTirzepatide
94 papers6 new in 30 days